Fig. 1From: Efficacy and safety evaluation of a novel trioxaquine in the management of cerebral malaria in a mouse modelStructure of trioxaquine: N-(7-chloroquinolin-4-ylamino)-ethyl-artesunate-19-carboxamideBack to article page